LSNE Highlights Milestones; Samsung BioLogics Licensed by Health Canada; Novacap Acquires PCI Synthesis and More in Today’s Week in Review
 Trouble viewing this email? Read it online
Follow us on:       
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by ECOLAB

Video: LSNE Highlights Major Milestones at BIO
COO explains company's new acquisition and expansion
Watch the Video >>

Video: Pii Continues To Lead in Pharma Product Development
Pii’s senior business development director, Gregory Gonzales, spoke with Contract Pharma at BIO about services & recent news
Watch the Video >>

Removing Water Baths: Simplify Hepatocyte Thaws, Eliminate Contamination
By eliminating the need for water baths, a significant source of tissue culture contamination can be removed, efficiency is increased and performance variability is decreased...

Video: Avista Pharma Details One-Stop-Shop Offerings
Analytical services director, Katie Schlipp, spoke with Contract Pharma at BIO 2018
Watch the Video >>

Samsung BioLogics Licensed by Health Canada
To manufacture a monoclonal antibody drug substance at its first plant

GlobePharma introduces the SIFT-N-BLEND™powder blender
The new technology features an interchangeable built-in screening mechanism that eliminates the need to pre-screen any materials.
Learn More >>

Novacap Acquires PCI Synthesis
Expands pharma offering in the U.S.

CASI Pharma, Yiling Wanzhou in Strategic Mfg. Pact
CASI to manufacture entecavir and cilostazol

Pharmaceutical Brand Awareness Survey
Complete our Pharmaceutical Brand Awareness Survey and receive a $5 GIFT CARD and a chance to Win a $2500 travel voucher.
Take the Survey >>

CellGenix Expands Germany HQ
An automated filling and freeze-drying line will be implemented in the existing GMP facility as phase 2 of the expansion Read More >>

MHRA Grants MeiraGTx Manufacturer’s Authorization
Enables the manufacture of gene therapy product candidates in current cGMP compliant facility

Umicore API Facility Passes cGMP Audit
The plant manufactures four oncology APIs produced for global markets according to the latest international guideline

Mettler Toledo to Host Grand Opening in Lutz, FL
New 265,000 sq.-ft. office and manufacturing space houses three business units

Syneos, Elligo Enter Strategic Collaboration
To build a central infrastructure & research system around physicians & patients who aren't accessible in traditional sites


JUNE 2018


70 Years - Buchiglas Uster
Buchiglas is a leading manufacturer of reactor systems and pilot plants for API and fine chemicals Synthesis.

Microsite Spotlight

Alcami is a world-class contract development and manufacturing organization (CDMO) headquartered in North Carolina, with executive offices in Durham and Wilmington. With over 1,000 employees operating at nine global locations, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services. .

We hope you enjoyed this edition of Contract Pharma Direct's Friday Week in Review.

You are receiving this message because you opted in at To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address ( to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Ste 200
Montvale, NJ 07645
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2018 Contract Pharma All rights reserved.